Tanamoto K, Zähringer U, McKenzie G R, Galanos C, Rietschel E T, Lüderitz O, Kusumoto S, Shiba T
Infect Immun. 1984 May;44(2):421-6. doi: 10.1128/iai.44.2.421-426.1984.
Chemically synthesized lipid A analogs were investigated for several endotoxic activities, including pyrogenicity, lethal toxicity, anticomplement activity, and the capacity to gelate Limulus amoebocyte lysate in comparison to natural lipid A. The synthetic preparations contained D-glucosamine or D-glucosamine-beta-1,6-D-glucosamine disaccharide substituted by ester- and amide-bound hydroxylated or non-hydroxylated fatty acids and by phosphate groups in different combinations. Some preparations which were insoluble in water were succinylated and thus rendered more soluble. Strong biphasic pyrogenic responses with a maximal increase in body temperature of 1 to 2 degrees C were obtained with 50 micrograms/kg doses of 3 disaccharide preparations of 15 tested. With two preparations (50 micrograms/kg) moderate pyrogenicity with monophasic fever curves and a maximal temperature increase of about 0.6 degrees C was obtained. Lethal toxicity tests were carried out in galactosamine-sensitized mice. Of 15 synthetic preparations, 4 exhibited lethal toxicity under these conditions. The effective doses of the lipid A analogs in both in vivo tests were, however, several hundred times higher than those of bacterial lipid A. For the activities in vivo, hydroxyacyl residues seemed to be important. Anticomplement activity was demonstrable in seven preparations, one of which expressed an activity comparable to that of lipid A. Preparations containing non-hydroxylated fatty acids seemed to be most active in this test. None of the synthetic preparations was found to exhibit gelation activity for Limulus amoebocyte lysate when tested in doses up to 0.4 micrograms, whereas bacterial free lipid A was active in doses of about 2 pg. None of the monosaccharide derivatives exhibited any of these activities.
对化学合成的类脂A类似物进行了多种内毒素活性研究,包括致热原性、致死毒性、抗补体活性,以及与天然类脂A相比使鲎变形细胞溶解物凝胶化的能力。合成制剂包含D-葡糖胺或D-葡糖胺-β-1,6-D-葡糖胺二糖,它们被酯键和酰胺键连接的羟基化或非羟基化脂肪酸以及磷酸基团以不同组合取代。一些不溶于水的制剂经琥珀酰化处理后溶解性增强。15种测试的二糖制剂中,有3种以50微克/千克的剂量给药时产生了强烈的双相热原反应,体温最大升高1至2摄氏度。另外两种制剂(50微克/千克)产生了单相发热曲线的中度热原性,体温最大升高约0.6摄氏度。在半乳糖胺致敏的小鼠中进行了致死毒性试验。15种合成制剂中,有4种在这些条件下表现出致死毒性。然而,类脂A类似物在这两种体内试验中的有效剂量比细菌类脂A的有效剂量高出数百倍。对于体内活性而言,羟酰基残基似乎很重要。在7种制剂中可证明有抗补体活性,其中一种的活性与类脂A相当。含非羟基化脂肪酸的制剂在该试验中似乎最具活性。当以高达0.4微克的剂量进行测试时,未发现任何一种合成制剂对鲎变形细胞溶解物表现出凝胶化活性,而无细菌的类脂A在约2皮克的剂量下具有活性。单糖衍生物均未表现出任何这些活性。